Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03107754 · ClinicalTrials.gov registry record · Phase 4
Buffered Lidocaine in Paracervical Blocks
A Phase 4 study, sponsored by University of Hawaii.
- Completed
- Registry status
- Phase 4
- Development phase
- 98
- Enrollment target
NCT03107754 is a Phase 4 study that has completed, run by University of Hawaii. The registered enrollment target is 98 participants.
The verdict
NCT03107754, a Phase 4 study, has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 98 participants
- Enrollment target
Study Summary
For pain relief during a first trimester surgical aspiration, most providers use the paracervical block, either alone or in combination with other pain control techniques. Some providers use buffered lidocaine due to a belief that it decreases pain. Others use plain lidocaine. At our clinics, the standard pain management protocol is using 20 cc of 1% plain lidocaine in a two site injection. Few studies have compared buffered versus unbuffered lidocaine for paracervical blocks during first trimester uterine aspirations. This study seeks to determine if buffered lidocaine decreases injection pain versus plain lidocaine for paracervical blocks.
Interventions
- DRUG Lidocaine
- DRUG Lidocaine-Sodium Bicarbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2018-10-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03107754
The ClinicalTrials.gov registry entry for NCT03107754 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine is the first listed.
NCT03107754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03107754 about?
NCT03107754 is a clinical study titled "Buffered Lidocaine in Paracervical Blocks". For pain relief during a first trimester surgical aspiration, most providers use the paracervical block, either alone or in combination with other pain control techniques. Some providers use buffered lidocaine due to a belief that it decreases pain. Others use plain lidocaine. At our clinics, the st...
What is the current status of trial NCT03107754?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 98 participants. The study started on 2017-05-15. Estimated completion is 2018-10-25.
What interventions are being tested in trial NCT03107754?
The interventions under investigation include: Lidocaine (DRUG), Lidocaine-Sodium Bicarbonate (DRUG).
Who is sponsoring clinical trial NCT03107754?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.